A Study of the Investigational Monoclonal Antibody, VYD2311, in Healthy Participants

To Assess the Safety and Tolerability of MTx-COVAB36 as a Therapeutic and Prophylactic Treatment Against COVID-19.

NCT05351437 ·Status: COMPLETED ·Phase: PHASE1

A Phase 1 Study to Evaluate the Safety and Immunogenicity of COVID-19 Vaccine

NCT06113744 ·Status: RECRUITING ·Phase: PHASE1

A Study of Human Monoclonal Antibodies, BRII-196 and BRII-198

NCT04787211 ·Status: COMPLETED ·Phase: PHASE2

Safety and Immunogenicity Study of a SARS-CoV-2 (COVID-19) Variant Vaccine (mRNA-1273.351) in Naïve and Previously Vaccinated Adults

NCT04785144 ·Status: COMPLETED ·Phase: PHASE1

Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19

NCT04412538 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Safety and Immunogenicity of a Sub-unit Protein CD40.RBDv Bivalent COVID-19 Vaccine, Adjuvanted or Not, as a Booster in Volunteers.

NCT06255626 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

A PhaseⅡ Study to Evaluate the Safety & Immunogenicity of SARS-CoV-2 Alpha/Beta/Delta/Omicron Variants COVID-19 Vaccine

NCT05652543 ·Status: COMPLETED ·Phase: PHASE2

Safety and Tolerability of Regeneron Anti-SARS-CoV-2 Monoclonal Antibody/Ies in Adult Healthy Volunteers as Related to COVID-19

NCT05293678 ·Status: COMPLETED ·Phase: PHASE1

A Phase I/II Clinical Trial in Healthy People Aged 18 Years and Above

NCT05144139 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Study to Assess the Safety, Tolerability and Explore the Immunogenicity of EG-COVID and EG-COVARo in Healthy Adult Volunteers

NCT05188469 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Safety, Tolerability, and Pharmacokinetics Study of Human Monoclonal Antibody BRII-196

NCT04479631 ·Status: COMPLETED ·Phase: PHASE1

Immune Responses to COVID-19 Infection or Vaccination

NCT05379478 ·Status: COMPLETED

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of MVC-COV1901 or MVC-COV1901(Beta) Against COVID-19

NCT05216601 ·Status: COMPLETED ·Phase: PHASE1

Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for Hospitalized Adult Patients With COVID-19

NCT04426695 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Phase 1 Single-ascending Dose Study to Evaluate Safety and Tolerability of MEDI4920 in Healthy Adults

NCT02151110 ·Status: COMPLETED ·Phase: PHASE1

COVID-19 Vaccination Using a 2nd Generation (E1/E2B/E3-Deleted) Adenoviral-COVID-19 in Normal Healthy Volunteers

NCT04591717 ·Status: COMPLETED ·Phase: PHASE1

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Neutralizing Antibody BGB-DXP593 in Participants With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19)

NCT04551898 ·Status: COMPLETED ·Phase: PHASE2

A Phase 1 Study of Human Monoclonal Antibodies, BRII-196 and BRII-198

NCT04691180 ·Status: COMPLETED ·Phase: PHASE1

Safety, Tolerability, and Immunogenicity of Trivalent Coronavirus Vaccine Candidate VBI-2901a

NCT05548439 ·Status: COMPLETED ·Phase: PHASE1

Safety and Pharmacokinetics Study of Human Monoclonal Antibody (AVP-21D9)

NCT01202695 ·Status: COMPLETED ·Phase: PHASE1

A Trial of NT-I7 in COVID-19 (SPESELPIS)

NCT04501796 ·Status: TERMINATED ·Phase: PHASE1

SARS-CoV-2-Neutralizing Monoclonal COVID-19 Antibody DZIF-10c by Infusion

NCT04631666 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

The Safety and Immunogenicity of SCTV01C in Healthy Population Aged ≥18 Years Previously Vaccinated With mRNA COVID-19 Vaccine.

NCT05043311 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Human COVID-19 Immunoglobulin (COVID-HIG) Therapy for COVID-19 Patients

NCT05173441 ·Status: UNKNOWN ·Phase: PHASE2

A Study on the Safety and Immune Response of Investigational COVID-19 mRNA Vaccines in Healthy Adults

NCT05960097 ·Status: COMPLETED ·Phase: PHASE2